Clinical trial
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women…
NCT00003771 · Regional Oncologic Center, Other · Completed
Key facts
| NCT number | NCT00003771 |
|---|---|
| Title | Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer |
| Official title | Protocol for Randomized Clinical Study Concerning Hormonal Replacement Therapy (HRT) After Previous Radical Breast Cancer Treatment |
| Lead sponsor | Regional Oncologic Center, Other |
| Collaborators | Scandinavian Breast Group ETOP IBCSG Partners Foundation European Organisation for Research and Treatment of Cancer - EORTC |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Menopausal Symptoms |
| Intervention type | Biological, Drug |
| Interventions | therapeutic estradiol, norethindrone acetate |
| Enrollment | 1,300 |
| Start date | Sep 1, 1997 |
| Completion | Feb 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | Finland, Norway, Poland, Sweden, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: